Secretion of Cardiac Plasminogen Activator During Hypoxia-induced Right Ventricular Hypertrophy

By Bansal D.D.   Klein R.M.   Hausmann E.H.S.   MacGregor R.R.  

Journal of Molecular and Cellular Cardiology, Vol. 29, Iss. 11, 1997-11 ,pp. : 3105-3114

Academic Press

Access to resources Recommend Favorite

Effects of angiotensin II receptor blockade‐based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients

By Cuspidi Cesare   Meani Stefano   Valerio Cristiana   Fusi Veronica   Sala Carla   Maisaidi Meilikemu   Zanchetti Alberto  

Blood Pressure, Vol. 15, Iss. 2, 2006-04 ,pp. : 107-115

Informa Healthcare

Access to resources Recommend Favorite

Life after LIFE. Cardiovascular benefits of angiotensin II receptor blockade in older people with essential hypertension, left ventricular hypertrophy and diabetes mellitus

By Giacomelli V.O.   Singer D.R.J.  

European Journal of Internal Medicine, Vol. 13, Iss. 6, 2002-09 ,pp. : 353-355

Elsevier

Access to resources Recommend Favorite

Tissue Angiotensin II During Progression or Ventricular Hypertrophy to Heart Failure in Hypertensive Rats; Differential Effects on PKCɛ and PKCβ

By Inagaki K.   Iwanaga Y.   Sarai N.   Onozawa Y.   Takenaka H.   Mochly-Rosen D.   Kihara Y.  

Journal of Molecular and Cellular Cardiology, Vol. 34, Iss. 10, 2002-10 ,pp. : 1377-1385

Academic Press

Access to resources Recommend Favorite

Left Ventricular Hypertrophy and Angiotensin II Receptor Blocking Agents

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 3, Iss. 1, 2005-01 ,pp. : 61-67

Bentham Science Publishers

Access to resources Recommend Favorite